Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

Recruiting

IvermectinObservational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

Sponsor:

Patrick Robinson

Code:

NCT05045937

Conditions

Covid19

COVID-19 Pneumonia

COVID-19 Respiratory Infection

COVID-19 Acute Bronchitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Accepted

Interventions

Ivermectin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Patrick Robinson on 2022-04-27.